Impact of receiving recorded mental health recovery narratives on quality of life in people experiencing non-psychosis mental health problems (NEON-O Trial)

Not Applicable

Completed

• Conditions: Mental health; Mental and Behavioural Disorders

• Registration Number: ISRCTN63197153
• Lead Sponsor: ottinghamshire Healthcare NHS Foundation Trust

Brief Summary

2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32690105/ protocol (added 22/07/2020) 2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35093141/ updated protocol (added 31/01/2022) 2022 Other publications in https://doi.org/10.3389/fpsyt.2022.1028156 Development and delivery cost (added 27/06/2023) 2023 Interim results article in https://doi.org/10.2196/44687 Baseline data analysis (added 13/07/2023) 2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38214639/ (added 13/02/2024)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-01-09
• Study Completion: 2022-09-22
• Last Update Posted: 27 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1023

Inclusion Criteria

1. Aged 18 years and above
2. Any gender
3. Experinece of mental health problem other than psychosis in the last five years
4. Experience of mental health-related distress in previous 6 months
5. Resident in England
6. Able to understand written and spoken English
7. Able to access or be supported to access the internet
8. Able to give online informed consent.

Exclusion Criteria

1. If included in the NEON Trial (ISRCTN number: ISRCTN11152837)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Manchester Short Assessment (MANSA) of health-related quality of life, captured at 1 week, 12 weeks and 52 weeks (primary endpoint) after baseline.

Secondary Outcome Measures

Name	Time	Method
Secondary outcome measures will be assessed at baseline, one week, 12 weeks and 52 weeks after baseline:<br>1. Hope will be assessed through the Herth Hope Index<br>2. Meaning in Life will be assessed through the Meaning in Life Questionnaire<br>3. Empowerment will be assessed through the Mental Health Confidence Scale<br>4. Symptomatology will be assessed through the CORE-10